Flex Biomedical develops treatments for orthopedic diseases and offers Flex Polymer, a synthetic polymer designed to treat osteoarthritis.
Flex Biomedical, a Madison-based company founded in 2007, is developing innovative treatments for orthopedic diseases. The company's lead product, the Flex Polymer™, is a synthetic polymer designed to treat osteoarthritis, an incurable, debilitating joint disease that affects 27 million people in the United States and 100 million people worldwide.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Jun 20, 2012 | Series Unknown | $881.66K | 1 | NEW Capital Fund | — | Detail |
Aug 14, 2009 | Series Unknown | $0.98M | 1 | — | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
NEW Capital Fund | Yes | Series Unknown |